GHTF (Global Harmonization Task Force) gets to grips with strategy
This article was originally published in Clinica
The Global Harmonization Task Force (GHTF) steering committee was hammering out a strategic direction for the group as Clinica went to press. Meeting in Sydney, Australia, in the first formal session under the current management of Australia's Therapeutic Goods Administration (TGA), the group was scheduled to focus on practices and procedures drafted by the US FDA that are intended for implementation by the GHTF.
You may also be interested in...
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.